News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
4h
TipRanks on MSNBullish flow in Hims and Hers Health (HIMS), with shares up $5.54 (+10.04%) near $60.76.Options volume is more than double the daily average, with 105k contracts traded and calls leading puts for a put/call ratio of 0.53, compared to a typical level near 0.61. Implied volatility (IV30) ...
4d
Zacks Investment Research on MSNIs Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
StockStory.org on MSN9d
Hims & Hers Health Earnings: What To Look For From HIMSTelehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results tomorrow after the bell. Here’s what investors ...
Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...
Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant ...
Hims & Hers Health ( HIMS) shares surged 8% Tuesday, a day after the health and wellness platform posted better-than-expected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results